| HNRPU Protein | |
|---|---|
| Protein Name | HNRPU Protein (hnRNP U) |
| Gene | HNRNP U |
| UniProt ID | Q00839 |
| PDB IDs | 2JY6, 5G3S |
| Molecular Weight | 120 kDa |
| Subcellular Localization | Nucleus (nuclear matrix) |
| Protein Family | HnRNP family, SAF-A/Scaffold attachment factor |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Alzheimer's Disease |
HNRPU (hnRNP U) is a nuclear matrix protein that plays critical roles in RNA metabolism, chromatin organization, and gene expression regulation. Also known as Scaffold Attachment Factor A (SAF-A), this protein is essential for proper RNA splicing and has been implicated in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and Alzheimer's disease.
HNRPU is a 806-amino acid protein with a modular architecture that enables its diverse functions:
The protein contains multiple nuclear localization signals (NLS) and is heavily modified by phosphorylation, sumoylation, and methylation, which regulate its interactions and function in transcription and RNA processing[1].
HNRPU is a multifunctional nuclear protein that participates in:
HNRPU regulates alternative splicing of pre-mRNA, particularly for genes involved in neuronal function and survival. It interacts with the spliceosome machinery and modulates the inclusion or exclusion of specific exons[2].
HNRPU also plays a role in:
As Scaffold Attachment Factor A (SAF-A), HNRPU anchors chromatin loops to the nuclear matrix, creating transcriptionally active domains. This function is essential for proper gene expression patterns in neurons. The protein binds to scaffold/matrix attachment regions (S/MARs) and facilitates higher-order chromatin structure.
HNRPU interacts with the Survival Motor Neuron (SMN) complex, which is essential for spliceosomal snRNP assembly. In neurons, HNRPU regulates SMN complex function and splicing of genes critical for synaptic transmission[3]. The collaboration between HNRPU and SMN is crucial for motor neuron survival.
The protein interacts with RNA polymerase I and II, various transcription factors, and chromatin-associated proteins to regulate gene expression at multiple levels. HNRPU also participates in:
HNRPU dysfunction contributes to ALS pathogenesis through impaired RNA processing of critical neuronal transcripts. Studies have shown altered HNRPU expression and localization in ALS motor neurons, leading to defective RNA metabolism[4].
In SMA, impaired HNRPU function disrupts SMN complex activity, leading to defective spliceosomal snRNP assembly and subsequent loss of motor neuron survival. The connection between HNRPU and SMN function is critical for understanding SMA pathogenesis.
Recent research has revealed that HNRPU regulates alternative splicing in Alzheimer's disease, with altered splicing patterns observed in AD brain tissue[5]. HNRPU dysfunction may contribute to AD pathogenesis through impaired RNA processing of genes involved in synaptic function and neuronal survival.
Mutations in HNRNP U cause neurodevelopmental disorders characterized by intellectual disability, speech delay, and motor impairments. These findings underscore the essential role of HNRPU in brain development[6].
Compounds that enhance proper RNA splicing represent a therapeutic strategy for HNRPU-related disorders. These modulators aim to restore normal splicing patterns disrupted by HNRPU dysfunction.
Agents that compensate for HNRPU-related SMN dysfunction may benefit SMA patients. The close relationship between HNRPU and SMN complex function makes this an attractive target.
Modulating HNRPU expression or function through viral vector-mediated gene delivery represents a potential therapeutic approach for neurodegenerative diseases.
Antisense oligonucleotides (ASOs) targeting aberrant splicing events caused by HNRPU dysfunction offer a precise therapeutic strategy.
Kukalev A, et al. hnRNP U in gene regulation. Exp Cell Res. 2005. ↩︎
Damgaard CK, et al. hnRNP U in neuronal RNA processing. J Mol Neurosci. 2019. ↩︎
Zhang Q, et al. hnRNP U in spinal muscular atrophy. Hum Mol Genet. 2018. ↩︎
Yamada H, et al. hnRNP U and ALS. Neurobiol Aging. 2021. ↩︎
Chen Y, et al. hnRNP U regulates alternative splicing in Alzheimer's disease. Nat Neurosci. 2022. ↩︎
Roach L, et al. hnRNP U mutations cause neurodevelopmental disorder. Brain. 2020. ↩︎